Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis

Rhinology

Volumn 47, Issue 2, 2009, Pages 166-171

  Braak, S J ^a   De Witt, C A ^a   Disch, F J M ^a   Overtoom, Th C ^a   Westermann, J J ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Complications; Embolization; Epistaxis; Hereditary hemorrhagic telangiectasia; Impact factor; Impact on lifestyle

Indexed keywords

ARTICLE; ARTIFICIAL EMBOLISM; EPISTAXIS; FEMALE; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; QUESTIONNAIRE; RENDU OSLER WEBER DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EMBOLIZATION, THERAPEUTIC; EPISTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 68149094336     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aasar S, Friedman C, White J. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 1991; 101: 977-980.
2. Westermann CJ, Rosina AF, de Vries V, de Coteau P. The prevalence and manifestations of hereditary hemorraghic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: A family screening. Am J Med Genet 2003; 116A: 324-328.
3. Lesca G, Olivieri C, Burnichon N, et al; French-Italian-Rendu-Osler Network. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med. 2007 Jan; 9:14-22.
4. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-67.
5. Haitjema T. Balderd W, Disch FJM, Westerman CJJ. Epistaxis in hereditary hemorraghic telangiectasia. Rhinology 1996; 34: 176-178.
6. Pau H, Carney AS, Murty GE. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngology manifestations. Clin. Otolaryngol. 2001; 26: 93-98.
7. Maceri DR, Makielski KH. Intraoral ligation of the maxillary artery for posterior epistaxis. Laryngoscope 1984; 94: 737-741.
8. Sokoloff J, Wickbom I, McDonald D, Brahme F, Goergen TC, Goldberger LE. Therapeutic percutaneous embolization in intractable epistaxis. Radiology 1974; 111: 285-287.
9. McCaffrey TV. Kern EB, Lake CF. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol. 1977; 103: 627-630.
10. Parnes, LS, Heeneman, H, Vinuela, F. Percutaneous embolization for control of nasal blood circulation. Laryngoscope 1987; 97: 1312-1315.
11. Layton KF, Kallmes DF, Gray LA, Cloft HJ. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia. Am J Neuroradiol. 2007; 28: 885-888.
12. Elden L, Montanera W, Terbrugge K, Willinsky R, Lasjaunias P, Charles D. Angiographic embolization for the treatment of epis-taxis: a review of 108 cases. Otolaryngol Head Neck Surg. 1994; 111:44-50.
13. Fischer M, Dietrich U, Labisch C, Zanella FE, Jahnke K. Kritische beurteilung der gefȧ βembolisation bei Morbus Rendu-Osler. Laryngo-Rhino-Otol. 1997; 76: 490-494.
14. Christensen NP, Smith DS, Barnwell SL, Wax MK. Arterial embolization in the management of posterior epistaxis. Otolaryngol Head Neck Surg. 2005; 133: 748-753.